Member Info for tombi1

could that news were waiting for be very close , big volume someone wants in

big buys today ,way above the average traded

it will all be down to the chinese ,americas contracts ,which we are not privy to yet , who knows whats in them , one great deal could completely turn this company around

i thought all as expected ,everything hangs on china deal , how good it is and what comes out in americas , could be very exciting ,enough funds for 12 months + , news is very close

must be any day now ,been a little while and they said expect news soon ,so fingers crossed comes soon and excites the market and the share can finally get moving

expect something anytime now ,hopefully give sp big boost

buys already ,no one seems to be selling

buys

lots of buying coming in ,overhang could be cleared

rise

brought so far today

i can see this hitting the 1p very soon , the bullish outlook and charts bullish , looks good short term at least

seems to be carrying on ,

some nice buys coming in

maybe ,once they are gone should move then

very positive statement

Broker N+1 Singer which has thus far been pretty spot on, anticipates revenues of £28m for this year, rising to £32m by 2016, which should in turn see pre-tax profits of £3m and £3.5m delivered. Having previously snapped up Inverclyde Biologicals, SBS subsequently moved for the much larger Vindon healthcare operation stumping up £12.2m for the business, part of which was funded via a well supported placing raising £9.5m. Although the group is currently in a net debt position due to the acquisitions and expansion programme, it is nevertheless cash generative and profitable. The next few years should deliver a move into a net cash situation of close to £4m, while there will also be sizeable assets, including the Nottingham HQ, by 2017. Although SBS has been largely focused on the UK, boasting operations that include Cambridge and Oxford, it has also moved further afield. Ireland and Germany have been on its map for some time, while a more recent presence in the US is now presenting serious nearer term upside for the business

why do you think more dilution

buy ,nice

Outlook Results for the year ended 31 December 2013 demonstrated another year of strong growth for the business and trading for the early part of 2014 continues to build on the robust operational performance of the Group. We look forward to updating shareholders further following the publication of our Half Year Report for the six months ending 30 June 2014, anticipated to be released in August 2014."